Ipilimumab Injection 50mg and 200 mg vial
- Name: Yervoy
- Generic Name: Ipilimumab
- Strength: Single use-vial
- Manufactured: Bristol-Myers Squibb Company
- Ipilimumab was approved by the US Food and Drug Administration in the year of 2011 for treating patients with late-stage Melanoma that has spread or can not be removed by the surgery. It is a type of deadly skin cancer.
- Later, it was approved for the stage 3 patients as adjuvant therapy.
- On February 1, 2012, Ipilimumab was approved by Health Canada for the treatment of unresectable or metastatic melanoma in those patients who have failed or do not tolerate other systemic therapy for advanced disease.
- In November 2012, Ipilimumab was approved in the European Union, for the treatment of second line metastatic melanoma.
- The drug is undergoing clinical trials for the treatment of NSCLC, small cell lung cancer and metastatic hormone-refractory prostate cancer and bladder cancer.
- Ipilimumab is the active ingredient of Yervoy.
- It is unspecified if this drug is safe as well as effective in children who are less than 18 years of age.
- It is given to the patient into their vein through an IV line over 90 minutes.
- Yervoy FDA label should be stored under refrigeration at 2°C to 8°C (36°F to 46°F). Never freeze it. Vials should be protected from light.
- when your skin cancer melanoma has spread or not able to be removed by the surgery.
- In order to help prevent melanoma from coming back after it and lymph nodes that contain cancer have been removed by surgery.
Melanoma, also can be addressed as malignant melanoma. It is a type of skin cancer that begins from the pigment-producing cells called Melanocytes. Melanomas typically occur in the skin but can rarely occur in the mouth, intestines or eye. In females, it most commonly occurs on the legs, while in males it most commonly occurs on the back. Approximately 25% of melanomas begins from moles. Changement in the mole that may indicate melanoma include an increment in the size, irregular edges, skin breakdown, change in color and itchiness.
- Surgery for Melanoma Skin Cancer
- Immunotherapy for Melanoma Skin Cancer
- Targeted Therapy Drugs for Melanoma Skin Cancer
- Chemotherapy for Melanoma Skin Cancer
- Radiation Therapy for Melanoma Skin Cancer
Stage 4 melanoma also can be specified as metastatic melanoma; it means the cancerous cells start spreading beyond the skin and regional lymph nodes to the distant organs such as the lungs, liver or brain. In this stage cancer also has spread to the distant lymph nodes and also areas of the skin.
In order to treat advanced stage Melanoma, Ipilimumab is quite popular amongst healthcare providers. The drug is effective in deadly skin cancer treatment (Melanoma).
Ipilimumab is available as 50 mg vial (5 mg/mL) and 200 mg vial (5 mg/mL) Single use-vial
Is there any generic or bio similar available for Yervoy (Ipilimumab 50 mg and 200 mg).
There is no generic or bio similar available for Yervoy (Ipilimumab 50 mg and 200 mg) anywhere in the world.
What is price of one vial of Yervoy (Ipilimumab 50 mg and 200 mg)?
You can call /at whats app +91-9310090915 or send mail to info@indianpharmanetwork.com know the price.
Is it safe to buy Yervoy (Ipilimumab 50 mg and 200 mg) in India from local distributor?
It is always better to check the credential of the person / distributor before confirming.
As per the legal guidelines, only patients can import the product after getting proper documentation.
Patients must check following documents before importing Yervoy?
- How the product entered in India
- How is the packaging
- Courier / Shipping Details
- Verification of the foreign supplier e.g. drugs license and government approval of the ware house etc.
- Import documents
- Bill of entry of custom department
Please do not buy Yervoy where cash payment in involved
How long does yervoy take to work?
You’ll receive YERVOY as an infusion in your vein. Typically, you’ll get one dose every three weeks for up to 4 doses. It takes about 90 minutes to get a full dose. Your healthcare provider may change how often you receive YERVOY or how long the infusion may take.
Send your enquiry to find Yervoy (Ipilimumab) in UAE Iraq, Iran, Saudi Arabia, Jordan, Mexico, Argentina, Brazil, Chile, Colombia, Peru, Venezuela, Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia, Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia, Algeria, Mauritius, Uganda, Zimbabwe. Australia and New Zealand. China, Cambodia, Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Hong Kong.
Are there any side-effects/ adverse reactions/precautions associated with treatment with Ipilimumab?
It is recommended to seek your doctor’s medical advice about side effects
How do I contact Indian Pharma Network?
You can reach us on Tollfree – +91 1800 889 1064 | 9310090915
Email: you can also sent enquiries directly to info@ikrispharmanetwork.com. We will respond within 24 hours after receiving your mail. Please mention detailed inquiry.
Conclusion: Ipilimumab is a first-in-class T-cell potentiator that has significant activity against stage IV melanoma. It has a significant improvement in the overall survival rate among patients with the metastatic melanoma, with the substantial long-term advantages observed among a subgroup of patients. However, adverse effects could be hazardous but can be manageable.
Contact Patient Support
If you have any questions or need any help, contact our Patient Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.
Disclaimer
CMV retinitis is kind of an eye infection caused by a virus. CMV mainly attacks the retina of the eye and can be responsible for causing loss of vision, and eventually may lead to the blindness. Patients with acquired immunodeficiency syndrome are more likely to develop CMV retinitis. CMV retinitis is kind of an eye infection caused by a virus. CMV mainly attacks the retina of the eye and can be responsible for causing loss of vision, and eventually may lead to the blindness. Patients with acquired immunodeficiency syndrome are more likely to develop CMV retinitis.